Cooper Consumer Health is a European leader in selfcare (non-prescription medicines, food supplements, and medical devices), established in January 2016 by private equity firm Charterhouse Capital Partners. It originates from the combination of French laboratoire Cooper and Dutch Vemedia Consumer Health.
Since then, Cooper Consumer Health has grown through successful follow-on acquisitions of strong brand portfolios, such as Hexomédine, Essaven, Dacryoserum.
Today, Cooper Consumer Health holds dominant positions in France, the Netherlands, Belgium, Italy, Spain, Portugal, and Hong-Kong. Its leading brands include Oenobiol, Valdispert, Pouxit, Insect Ecran, Excilor, and Audispray.
To find out more, visit us on cooperconsumerhealth.eu
Location: France, Ile-de-France
Employees: 501-1000
Founded date: 2016
Investors 4
Date | Name | Website |
09.11.2021 | CVC Capita... | cvc.com |
- | Damier Gro... | damiergrou... |
06.11.2020 | Charterhou... | charterhou... |
12.12.2021 | Avista Cap... | avistacap.... |
Mentions in press and media 1
Date | Title | Description | Source |
12.03.2021 | Charterhouse Capital Partners enters into exclusive negotiat... | London, 12th March 2021: Charterhouse Capital Partners LLP (“Charterhouse”), one of the longest esta... | avistacap.... |